Hengrui Therapeutics
PRIVATE
STATUS
Corporate
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Operator of a biopharmaceutical company. The company is engaged in the development and commercialization of cancer therapies. Its therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss.
Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 506 Carnegie Center
- Suite 102
- Princeton, NJ 08540
- United States
+1 (609) 000-0000
Hengrui Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Hengrui Therapeutics‘s full profile, request access.
Request full access to PitchBookHengrui Therapeutics Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Hengrui Therapeutics‘s full profile, request access.
Request full access to PitchBook